Skip to content
زونیساماید

Structure via PubChem · Public domain (PubChem)

EntityQ219957· pop 24· linked from 518 articles

زونیساماید

Sign in to save

Also known as AD-810, CI-912, PD-110843, Zonegran®, 1,2-Benzisoxazole-3-methanesulfonamide, 3-(Sulfamoylmethyl)-1,2-benzisoxazole, Zonisamide, Zonisamida

Zonisamide, sold under the brand name Zonegran among others, is a medication used to treat the symptoms of epilepsy and Parkinson's disease. Chemically it is a sulfonamide. It serves as an anticonvulsant used primarily as an adjunctive therapy in adults with Parkinson's disease, partial-onset seizures; infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic and generalized tonic clonic seizure. Despite this it is also sometimes used as a monotherapy for partial-onset seizures.

Chemical data

Formula
C8H8N2O3S
Molecular weight
212.23 g/mol
IUPAC name
1,2-benzoxazol-3-ylmethanesulfonamide
SMILES
C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
InChIKey
UBQNRHZMVUUOMG-UHFFFAOYSA-N
XLogP
0.2
Polar surface area
94.6 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2000
Admin. routes
oral
Indications
epilepsy, eating disorder, essential tremor, Seizure

via ChEMBL · EBI

Research

1,787 papers

via PubMed

Wikidata facts

Subclass of
sulfonamide
Mass
212.026
Has use
medication
Show 7 more facts
chemical formula
C₈H₈N₂O₃S
medical condition treated
migraine
canonical SMILES
C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
World Health Organisation international non-proprietary name
zonisamide
defined daily dose
0.2
subject has role
antioxidant
Commons category
Zonisamide
Sources (6)

via Wikidata · CC0